Regencell Bioscience Holdings Limited Ordinary Shares RGC

$9.71 +2.00% at last close

Analyst Consensus

Recent Analyst Actions

DateFirmActionRatingPrice Target
2018-01-02
B. Riley SecuritiesEric Wold
Downgrades Buy → Neutral —
2017-12-06
MacquarieChad Beynon
Downgrades Outperform → Neutral —
2017-12-06
MoffettNathansonRobert Fishman
Upgrades Sell → Neutral —
2017-12-06
RBC CapitalLeo Kulp
Downgrades Outperform → Sector perform —
2017-12-06
Loop CapitalDavid Miller
Downgrades Buy → Hold —
2017-12-05
WedbushMichael Pachter
Downgrades Outperform → Neutral —
2017-10-26
Morgan StanleyJames Luan
Maintains Equal-weight $17 → $18
2017-10-26
RBC CapitalLeo Kulp
Upgrades Sector perform → Outperform —
2017-10-25
B. Riley SecuritiesEric Wold
Maintains Buy $24 → $25
2017-10-23
Loop CapitalDavid Miller
Maintains Buy $25 → $24
2017-10-18
B. Riley SecuritiesEric Wold
Maintains Buy $26 → $24
2017-10-05
Morgan StanleyJames Luan
Upgrades Underweight → Equal-weight —
2017-09-28
Credit SuisseOmar Sheikh
Maintains Underperform $17 → $13
2017-09-05
MKM PartnersEric Handler
Upgrades Neutral → Buy —
2017-05-16
Loop CapitalDavid Miller
Upgrades Hold → Buy —
2017-02-01
Credit SuisseOmar Sheikh
Downgrades Neutral → Underperform —
2016-10-31
B. Riley SecuritiesEric Wold
Upgrades Neutral → Buy —
2016-08-24
Loop CapitalDavid Miller
Initiates coverage on Hold —
2016-07-27
JP Morgan
Maintains Neutral $21 → $23
2016-07-27
Hilliard Lyons
Downgrades Long-term buy → Neutral —
2016-07-18
RBC CapitalLeo Kulp
Downgrades Outperform → Sector perform —
2016-06-15
RBC CapitalLeo Kulp
Upgrades Sector perform → Outperform —
2016-06-13
Credit SuisseOmar Sheikh
Assumes Neutral $20
2016-03-30
B. Riley SecuritiesEric Wold
Downgrades Buy → Neutral —
2016-03-15
Credit SuisseOmar Sheikh
Maintains Neutral $19 → $20
2016-02-10
FBR Capital
Maintains Market perform $17 → $18
2016-02-05
Credit SuisseOmar Sheikh
Assumes Neutral $19
2016-01-26
RBC CapitalLeo Kulp
Downgrades Outperform → Sector perform $19
2016-01-14
Drexel Hamilton
Initiates coverage on Buy —
2015-10-15
Morgan StanleyJames Luan
Downgrades Equal-weight → Underweight $22 → $18

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$9.71
Market Cap
$4.72 billion
52-Week Range
$4.51 – $69.00
Average Volume
263K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.